Povorcitinib
- Generic Name
- Povorcitinib
A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 35
- Registration Number
- NCT03607487
- Locations
- 🇩🇪
Investigative Site, Lübeck, Schleswig-Holstein, Germany
🇨🇦Investigative Site 009, Markham, Ontario, Canada
🇨🇦Investigative Site 008, Richmond Hill, Ontario, Canada
A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 10
- Registration Number
- NCT03569371
- Locations
- 🇺🇸
Investigative Site, Hershey, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath